Motilium: Uses, dosage, side effects, warnings & patient reviews

What is Motilium (Domperidone)?

Motilium is a prescription medication containing the active ingredient domperidone. It belongs to a class of drugs known as dopamine antagonists with prokinetic and antiemetic properties. Domperidone works by blocking dopamine receptors in the upper digestive tract, which helps to increase movements and contractions in the stomach and intestines, facilitating gastric emptying.

Unlike some similar agents, domperidone does not readily cross the blood-brain barrier, which reduces its potential to cause certain neurological side effects. This medication is categorized under gastrointestinal drugs.

Important Regulatory Note: Domperidone is not approved by the U.S. Food and Drug Administration (FDA) for sale or distribution in the United States. The FDA has issued safety alerts regarding its use due to a risk of serious cardiac side effects. Availability, legal status, and approved indications vary significantly by country.

How to Take Motilium

Administration of Motilium must strictly follow a healthcare provider’s prescription. The following information represents general international dosing guidelines.

Administration and Timing

Motilium tablets are taken orally, typically 15 to 30 minutes before meals and, if needed, before bedtime. Taking it before a meal allows the medication to exert its prokinetic effect when food is in the stomach.

The tablets should be swallowed whole with a glass of water. Do not crush, split, or chew them unless specifically instructed by a doctor or pharmacist.

Duration of Treatment

Treatment duration should be as short as possible and not exceed the period recommended by the prescribing physician, usually limited to one week for common nausea and vomiting. Long-term use requires ongoing medical supervision due to potential risks.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

Side Effects of Motilium

All medications, including Motilium, can cause side effects. It is important to distinguish between common, manageable reactions and those that require immediate medical attention.

What is Motilium Used For?

Motilium is prescribed for the symptomatic relief of conditions related to slow gastric motility. Its use is subject to regional regulatory approval.

Primary Medical Uses

• Nausea and Vomiting: Relief of acute, episodic symptoms of nausea and vomiting.
• Dyspeptic Symptoms: Management of discomfort associated with delayed gastric emptying, such as postprandial fullness, early satiety, bloating, and upper abdominal discomfort. It may be used in the context of gastroesophageal reflux disease (GERD) when accompanied by these symptoms.
• Gastroparesis: Treatment of chronic, diabetic, or idiopathic gastroparesis to improve gastric emptying rates.

Nausea and vomiting treated by Motilium can stem from various causes, including those related to bacterial gastroenteritis.

Important Usage Clarifications

• Not an Antiemetic for Chemotherapy: It is not indicated for the prevention or treatment of nausea and vomiting associated with cancer chemotherapy or radiotherapy.
• Galactagogue Use (Off-label): The use of domperidone to stimulate breast milk production is a common off-label practice in some countries. This application is not FDA-approved and carries specific warnings regarding cardiac risk in the mother and unknown risks to the infant.

Important Safety Concerns and Considerations

Cardiovascular Risk

The most serious concern with domperidone is its association with dose-related QT interval prolongation on the electrocardiogram. This can lead to serious ventricular arrhythmias, including Torsades de Pointes, and an increased risk of sudden cardiac death. The risk is elevated with:

• Doses exceeding 30 mg per day.
• Pre-existing heart disease, particularly congestive heart failure.
• Concomitant use of other QT-prolonging drugs.
• Electrolyte imbalances (low potassium, low magnesium).
• Advanced age (over 60 years).

Hormonal Effects (Hyperprolactinemia)

As a dopamine antagonist, domperidone can elevate serum prolactin levels. This may lead to clinical manifestations such as galactorrhea (inappropriate milk secretion), breast enlargement and tenderness, menstrual irregularities in women, and reduced libido or impotence in men. These effects are usually reversible upon discontinuation of the drug.

Extrapyramidal Symptoms

Although less common than with other dopamine antagonists that cross the blood-brain barrier, extrapyramidal symptoms (e.g., acute dystonic reactions, akathisia) have been reported with domperidone, especially at high doses or in susceptible individuals.

Underlying Gastrointestinal Conditions

Motilium should not be used when gastrointestinal stimulation might be dangerous, such as in the presence of gastrointestinal hemorrhage, mechanical obstruction, or perforation.

Critical Warnings for Motilium Use

Cardiac Warnings and Contraindications

Motilium is contraindicated in patients with known pre-existing cardiac conduction disturbances (e.g., prolonged QT interval), significant electrolyte disturbances, or underlying cardiac diseases such as congestive heart failure. It should not be used in patients receiving other medications known to significantly prolong the QT interval or inhibit the CYP3A4 enzyme system.

Dosage and Duration Limitations

The recommended adult oral dosage should generally not exceed 10 mg three to four times daily. The total daily dose must not exceed 30-40 mg, depending on regional labeling. Treatment should be administered at the lowest effective dose for the shortest possible duration. Chronic use requires ongoing risk-benefit assessment by a physician.

Use in Patients with Liver Impairment

Domperidone is metabolized by the liver. Patients with moderate to severe hepatic impairment should use this medication with caution, as reduced clearance may lead to increased drug levels and a higher risk of adverse effects, including cardiac arrhythmias. Dose reduction may be necessary.

Galactagogue Use Warning

Healthcare providers and patients should be aware that the use of domperidone to increase milk production is an off-label application. This practice has not been approved by the FDA, which has issued specific warnings against it due to the potential for cardiac arrhythmias and sudden cardiac death in the mother. The risks to the breastfed infant are not fully known.

Motilium Dosage Information

Dosage must be individualized by a healthcare professional based on the condition being treated, patient response, and risk factors. The following table provides general international guidelines for adults.

Important Administration Notes

• Route: Oral tablets.
• Timing: Administer before meals for symptomatic relief related to food intake.
• Overdose: Symptoms may include drowsiness, disorientation, and extrapyramidal reactions. Cardiac monitoring is essential in suspected overdose due to arrhythmia risk.
• Prescription Status: Motilium is a prescription medication in most countries. For information on different drug classifications, see our guide to over-the-counter medicines.

Drug Interactions with Motilium

Domperidone is primarily metabolized by the liver enzyme CYP3A4. Concomitant use with drugs that affect this system or prolong the QT interval can lead to serious adverse events.

Additional Information

Storage and Handling

Store Motilium tablets at room temperature (between 15°C and 30°C or 59°F and 86°F), in a tightly closed container, away from light, excess heat, and moisture. Keep all medications out of the reach of children and pets.

Mechanism of Action Summary

Domperidone acts as a competitive antagonist at peripheral dopamine D2 and D3 receptors. In the gastrointestinal tract, this blockade results in increased esophageal sphincter tone, enhanced antral and duodenal contractions, and improved gastroduodenal coordination, all of which accelerate gastric emptying. Its antiemetic effect is mediated by antagonism of dopamine receptors in the chemoreceptor trigger zone (CTZ), located outside the blood-brain barrier in the area postrema.

Reporting Side Effects

If you experience any side effect, particularly a serious one, report it to your healthcare provider. You are also encouraged to report adverse drug reactions to your national drug regulatory authority (e.g., the FDA’s MedWatch program in the United States, or Health Canada’s Vigilance program). This contributes to ongoing drug safety monitoring.

References and Medical Sources

1. European Medicines Agency (EMA). Assessment report for domperidone-containing medicines. EMA/231226/2014. [2014].
2. Health Canada. Domperidone – Updated information on the recommended dose and contraindications. [2015].
3. U.S. Food and Drug Administration (FDA). FDA Talk Paper: FDA warns against women using unapproved drug, domperidone, to increase milk production. T05-06. [2004].
4. Drugs.com. Domperidone International Monograph. [Updated 2024]. https://www.drugs.com/international/domperidone.html
5. MedlinePlus. Domperidone. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a618032.html

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.